Hohimer Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Hohimer Wealth Management's GILD Position: Q4 2025 in Review
Hohimer Wealth Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,426 shares — an estimated $269K sold.
Hohimer Wealth Management first reported a position in GILD in Q4 2019 and held it in 21 quarters. The position peaked at $4.8M in Q4 2022. 2,227 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Hohimer Wealth Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Hohimer Wealth Management sold 2,426 Gilead Sciences shares in Q4 2025, an estimated $269K.
- Hohimer Wealth Management first reported a position in Gilead Sciences in Q4 2019 and held it in 21 quarters.
- Hohimer Wealth Management's Gilead Sciences position peaked at $4.8M in Q4 2022.
- 2,227 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Hohimer Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.